ICN Pharmaceuticals Inc. on Tuesday said it has receivedapproval from Hungary to sell the capsule form of its anti-viralribavirin to delay onset of AIDS.
The Costa Mesa, Calif. company (NYSE:ICN) in 1990 wonauthorization from Ireland to market the drug there for AIDStreatment.
The patent on ribavirin, trade named Virazole, is held byViratek Inc. (NASDAQ:VIRA), an ICN subsidiary.
The drug is approved for use in the United States as an aerosolin infants and young children hospitalized for severerespiratory infection with the respiratory syncytial virus.
(c) 1997 American Health Consultants. All rights reserved.